Facebook
X
LinkedIn
Forward
0653_SHSO_Pharmacy Grand Rounds - ISDA MDRO Guidelines_Live
Description:
The IDSA (Infectious Diseases Society of America) provides comprehensive guidelines for managing and preventing multidrug-resistant organisms (MDROs) in healthcare settings. These guidelines emphasize a multi-pronged approach for medically significant multi-drug resistant infections, including detailed recommendations for treatment based on recent clinical evidence and resistance patterns. Comparisons are made between new antimicrobial strategies vs. previous recommendations, highlighting resistance mechanisms and emerging therapies. IDSA MDRO guidelines apply to specific clinical cases, offering practical scenarios that help healthcare providers implement evidence-based practices when managing patients with suspected or confirmed MDRO infections. They also address the importance of interdisciplinary communication of MDRO status and the use of decolonization procedures to reduce transmission.
Target Audience
Pharmacists (PharmD)
Learning Objectives
After completing this activity, learners will be able to:
1.) Summarize key updates in the IDSA MDRO guidelines, including management of ESBL, AmpC, CRE/DTR-Pseudomonas, Stenotrophomonas, and CRAB infections
2.) Compare new antimicrobial strategies with previous recommendations, highlighting resistance mechanisms and emerging therapies
3.) Apply guideline recommendations to clinical cases
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
Brown DR, Henderson HI, Ruegsegger L, Moody J, van Duin D. Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales. Infect Control Hosp Epidemiol. 2023 Dec;44(12):2068-2070. doi: 10.1017/ice.2023.116.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– – Provider Designee/Verification: Fozia Ferozali, Ed.D
Phipson Wu, PharmD, BCPS
Navjot Kaur, PharmD
Alfred-John Roderos, PharmD
Kaitlin Vo, PharmD
David Winograd, PharmD
Phipson Wu, PharmD, BCPS
David Winograd, PharmD
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 ACPE
Pharmacy Credit - Accreditation Council of Pharmacy Education (ACPE)
Sutter Health designates this Live activity for a maximum of 1.00 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.